Gland Pharma receives Tentative Approval for Sugammadex Injection

#GlandPharma #INE068V01023 #GLAND #Pharmaceuticals #USFDA #TentativeApproval #SugammadexInjection

#Gland Pharma Q2 (Consolidated YoY):
- PAT at Rs 302.8 cr vs Rs 218.8 cr
- Revenue at Rs 1080.4 cr vs Rs 831.5 cr
- EBITDA at Rs 458 cr vs Rs 376 cr
- Margin 42.4 % vs 45.2%

#Gland Block Deal of 50,003 shares at Rs. 2265.00 worth 11.33 crore rupees at 1:41 PM